Should I Buy MTD? MTD 2026 Analysis

Should You Buy Mettler-Toledo International Inc (MTD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1373.570

1 Day change

-0.67%

52 Week Range

1525.170

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: price action is slightly bearish/indecisive and the stock is heading into earnings after-hours today, which makes the immediate entry less attractive for an impatient buyer.
If you must act now, the better tactic is to wait for the earnings reaction and buy only if it reclaims the ~~$1,398 pivot and holds above it; otherwise the next lower support zone (~~$1,365 then ~$1,345) is the more favorable dip area.
Medium-term setup is still constructive (Street targets mostly above spot and hedge funds increasing buying), but near-term sentiment is mixed (insiders selling and put-heavy option volume).

Technical Analysis

Trend/momentum: MACD histogram is negative (-6.737), indicating bearish momentum, but it is contracting (downtrend pressure is fading rather than accelerating).
RSI (6): 42.27, slightly weak but not oversold; suggests room for either a bounce or another leg down without a clear reversal signal yet.
Moving averages: converging MAs = consolidation/decision point rather than a clean trend.
Key levels:
- Pivot: 1,397.94 (current price 1,380.30 is below pivot → near-term bearish bias)
- Support: S1 1,365.11, then S2 1,344.83
- Resistance: R1 1,430.78, then R2 1,451.06
Pattern-based forward odds (provided): ~~50% chance of only ~0.04% next day move, but higher modeled upside over 1 week (~~+6.71%) and 1 month (~+2.45%)—i.e., near-term uncertain, modestly better skew beyond the immediate day.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

Positioning vs trading flow is split:
- Open interest put/call = 0.15 (call OI dominates → longer-standing positioning leans bullish).
- Put/call volume = 4.0 (today’s flow is put-heavy → near-term hedging/bearish sentiment into the event).
Volatility: IV 30d ~38.57 vs historical vol ~24.11 and IV percentile ~90 → options are priced for a larger-than-usual move (consistent with earnings/event premium).
Activity: today’s option volume is ~8.77x the 30-day average, confirming elevated event-driven positioning.

Technical Summary

Sell

Buy

Positive Catalysts

- Earnings catalyst: Q4 earnings due after-hours today (2026-02-05); a beat/raise can quickly push the stock back above the ~$1,398 pivot and toward ~$1,431 resistance.
- Hedge funds: “Hedge Funds are Buying,” with buying amount up ~127.44% QoQ (supportive medium-term demand signal).
- Analyst backdrop is mostly constructive with multiple Buy/Overweight ratings and price targets materially above current price.

Neutral/Negative Catalysts

- Earnings event risk today: the stock is currently below the pivot and options markets are pricing a large move; near-term direction is uncertain.
- Insider activity: “Insiders are Selling,” with selling amount up ~1109.66% over the last month (near-term sentiment negative).
- Options tape today is put-dominant (put/call volume 4.0), signaling defensive positioning into the report.
- Macro/news backdrop in the feed is cautious (jobs data, government funding uncertainty), which can weigh on risk appetite around results.

Financial Performance

Latest quarter provided: 2025/Q3
- Revenue: $1.03B, +7.87% YoY (solid top-line growth).
- Net income: $217.49M, +2.83% YoY (positive but slower than revenue).
- EPS: $10.57, +6.12% YoY (healthy earnings growth).
- Gross margin: 57.24%, down 1.41% YoY (some margin pressure despite growth).
Overall read: growth remains positive, but margin compression is a key watch item into Q4.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend (late 2025): broadly supportive with several upward target revisions post-Q3 and one notable upgrade.
- BofA: upgraded to Buy (PT $1,600).
- Citi: Buy, PT raised to $1,700.
- Stifel: Buy, PT $1,600.
- Barclays: Overweight, PT trimmed to $1,550 (still positive stance).
- Goldman: initiated Neutral, PT $1,475.
- Wells Fargo/Baird: more cautious (Equal Weight/Neutral; PTs ~$1,450 and ~$1,444).
Wall Street “pros” view: consistent execution, quality beats, and a tools-cycle recovery setup.
Wall Street “cons” view: valuation/macro sensitivity and timing of end-market recovery (biotech/academic/government spend) keeps some firms Neutral/Equal Weight.

9 Analyst Rating

Wall Street analysts forecast MTD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MTD is 1515 USD with a low forecast of 1444 USD and a high forecast of 1600 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

5 Hold

0 Sell

Moderate Buy

Current: 1382.850

Low

1444

Averages

1515

High

1600

Current: 1382.850

Low

1444

Averages

1515

High

1600

BofA

Buy

maintain

AI Analysis

2026-02-06

New

Reason

BofA

Price Target

AI Analysis

2026-02-06

New

maintain

Buy

Reason

BofA raised the firm's price target on Mettler-Toledo to $1,640 from $1,600 and keeps a Buy rating on the shares following a "strong" Q4 driven by execution and share gains rather than demand recovery. Q1 guidance looks "prudent" and "conservative," consistent with peers given the current macro backdrop, the analyst tells investors.

Barclays

Overweight

downgrade

2025-12-15

Reason

Barclays

Price Target

2025-12-15

downgrade

Overweight

Reason

Barclays lowered the firm's price target on Mettler-Toledo to $1,550 from $1,600 and keeps an Overweight rating on the shares. The firm adjusted ratings and price targets in the life sciences and diagnostics tools space as part of its 2026 outlook. The last of the estimate cuts, recovering end markets and tools being the "most under-owned space in healthcare" creates a "great setup" for outperformance of the tools group in 2026, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MTD

Unlock Now

MTD Should I Buy

MTD Should I Buy

Should You Buy Mettler-Toledo International Inc (MTD) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch